Certolizumab Drug Level ELISA (IDKmonitor®)

Product code: K9662 (96 wells)

Determination of free therapeutic certolizumab

Certolizumab is the Fab’ fragment of a recombinant humanised antibody conjugated to polyethylene glycol (PEG) and is therefore also known as “certolizumab pegol”. Certolizumab pegol (Cimzia®) is a TNF-alpha inhibitor used for the treatment of chronic inflammatory diseases, such as Crohn’s disease and rheumatoid arthritis. The IDKmonitor Certolizumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free certolizumab therapeutic drug in serum and EDTA plasma samples allowing clinicians to evaluate the drug efficacy and investigate primary non-response, loss of response and non-remission.

Download Brochure
Technical Support
Request a Quote

Key Advantages

Highly specific quantification of certolizumab drug levels in serum and EDTA plasma
Total incubation time 130 minutes
Saves costs by predicting efficacy of certolizumab therapy
Applicable to both gastroenterology and rheumatology
Reportable range 5.1-300 ug/ml
Automatable on ELISA automates (e.g. Dynex DS2)

Specifications

ELISA

40 tests

Storage: 2-8 °C

Blood sample

Test

Related Products

    076-20-Ustekinumab-Drug-Level-ELISA-IDKmonitor

    Ustekinumab Drug Level ELISA (IDKmonitor®)

    Ustekinumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Ustekinumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free ustekinumab in plasma or serum samples.

    076-20-Infliximab-Drug-Level-ELISA-IDKmonitor

    Infliximab Drug Level ELISA (IDKmonitor®)

    Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Infliximab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free infliximab in plasma or serum samples.

    076-20-Vedolizumab-Drug-Level-ELISA-IDKmonitor

    Vedolizumab Drug Level ELISA (IDKmonitor®)

    Vedolizumab is a recombinant protein used to treat Crohn’s disease and ulcerative colitis. The IDKmonitor Vedolizumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free vedolizumab in plasma or serum samples.

    076-20-TurbiPEL-Faecal-Pancreatic-Elastase-turbidimetric-assay

    Adalimumab Drug Level ELISA (IDKmonitor®)

    Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Adalimumab Drug Level ELISA kit is a microplate-based quantitative sandwich ELISA for the determination of free therapeutic TNFα antibodies (adalimumab) from plasma or serum samples.